CENCORA, INC. Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net
CENCORA, INC. (COR) had Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net of $173.96 million as of 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet · last filed 2013-11-26
- 2013-03-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $173.96M.
- 2012-12-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $31.04M.
- 2012-09-30: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $187.18M; Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net as first filed $33.20M.
- 2011-12-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $33.20M.
| Period end | Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net | Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net as first filed |
|---|---|---|
| 2013-03-31 | $173.96M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $31.04M 10-Q · filed 2013-02-08 | |
| 2012-09-30 | $187.18M 10-K · filed 2013-11-26 | $33.20M 10-K · filed 2012-11-27 |
| 2011-12-31 | $33.20M 10-Q · filed 2013-02-08 | |
| 2011-09-30 | $161.22M 8-K · filed 2013-07-16 | $43.35M 10-K · filed 2012-11-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |